Modified Hautmann Enterocystoplasty after Total Cystectomy for Bladder Tumor: Evolution Curve and Morbi-Mortality

Résumé fourni par la source

Introduction: Bladder cancer is the 2nd most common urological cancer after prostate cancer. Radical cystectomy (RC) with lymph node dissection and urinary diversion (UD) is considered the standard treatment for invasive localized bladder cancer. There are many variations of bladder replacement, the most common of which is the Hautmann bladder. Patients and Methods: The global objective of our study is to report the results of a retrospective analysis concerning 46 patients who benefited from a modified Hautmann type bladder replacement post cystectomy over a period of 8 years, from January 2014 to December 2021. This evaluation focuses on the evolution of Hautmann type enterocystoplasties as well as the factors favoring. Results: The evolution of the number of patients who received Hautmann bladder replacement has varied over the years with a peak in 2016 estimated at (26%), followed by the year 2015 (21%). The average age of the patients was 54 years. The preoperative general condition of the patients was evaluated using the ASA score. ASA 1 was predominant in the age group 50-59 years (100%). Short-term postoperative mortality: 1 death (2%) was objectified. 22 patients presented short-term complications, corresponding to a morbidity rate calculated at 47%. 2 deaths (4%) occurred late. Late morbidities were looked for and diagnosed during the follow-up consultations, with a rate of (17%). Discussion: The comparative study of the evolution curve of the number of patients who received a Hautmann type bladder replacement and those who received a non-continuous Bricker type urinary diversion showed variations with a peak in 2016 for the Hautmann type bladder replacement (26%) and a peak in 2021 for the Bricker type diversion (25.03%).

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.